Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - OTHER FINANCING ACTIVITIES
Other Financing Activities PRPH - ProPhase Labs, Inc.
1.2 M
LAST VALUE
0.00%
2 YEAR CAGR
28.84%
5 YEAR CAGR
46.14%
10 YEAR CAGR